Skip to content

Effect of remazolam besylate on postoperative recovery quality in patients undergoing prostate surgery

Effect of remazolam besylate on postoperative recovery quality in patients undergoing prostate surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100440
Enrollment
Unknown
Registered
2025-04-09
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental group:Patients received a slow bolus of sufentanil 0.2-0.4 µg/kg intravenously, and at the same time continued intravenous infusion of remimazolam besylate through intravenous administrat
Control group:The patient received a slow bolus of sufentanil 0.2-0.4 µg/kg intravenously, and at the same time continued intravenous infusion of propofol with a total amount of 1.5-2mg/kg for <=3 min

Sponsors

People's Hospital of Leshan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.18 years <= age <=80 years; 2.ASA Grade I - III; 3.18 kg/m^2 <=BMI <=28 kg/m^2; 4.Patients undergoing transurethral prostate surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: 1.Preoperative assessment of patients with difficult airway; 2.Patients who have contraindicated general anesthesia or plan to combine other anesthesia methods; 3.Patients with severe craniocerebral injury or major respiratory and circulatory organ dysfunction; 4.Patients with neuromuscular disease, mental illness or long-term use of benzodiazepines; 5.Patients with auditory or visual dysfunction or other conditions affecting normal communication; 6.Patients with a known allergy to any of the drugs involved in the study; 7.Patients who refused to participate in the study or did not cooperate with the study and who were determined by the investigator to be unfit to participate in the study.

Design outcomes

Primary

MeasureTime frame
Incidence of agitation in patients with PACU (RASS score >=3);

Secondary

MeasureTime frame
Study how long it takes to follow verbal commands after withdrawal;The time from drug withdrawal to laryngeal mask removal was studied;The time from the end of drug administration until subjects met the PACU criteria (the PACU criteria was the modified Aldrete score ?9 points);;Incidence of resedation after laryngeal mask removal (RASS score decreased by at least 1 point immediately compared to laryngeal mask removal);

Countries

China

Contacts

Public ContactLiang Jin

People's Hospital of Leshan

xzmzjl2828@163.com+86 833 2119359

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026